Bloomberg sources suggest Apple’s search for non-invasive blood glucose monitoring has reached the “proof-of-concept” stage and is good enough to be commercialised once the device is made smaller.
The technology, which utilises lasers to measure glucose content under the skin, has purportedly improved to the point that an iPhone-sized prototype is imminent.
It has been under development for a very long period. In 2010, under the leadership of Steve Jobs, Apple acquired the blood glucose monitoring business RareLight.
But, no-prick monitors pose a difficulty. In 2018, the health division of Alphabet, Verily, abandoned plans for a smart contact lens intended to detect glucose using tears.